Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta.
about
Bisphosphonate therapy in pediatric patientsThe management of osteoporosis in children.Bisphosphonate treatment for children with disabling conditions.Potential implications of cell therapy for osteogenesis imperfecta.Recent advances in osteogenesis imperfecta.Current and emerging treatments for the management of osteogenesis imperfecta.RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta.Approach to the child with fractures.Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfectaA Retrospective Study of Osteogenesis Imperfecta in Dakhliya region, Sultanate of Oman.Pamidronate affects the mandibular cortex of children with osteogenesis imperfecta.Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts.Bisphosphonate treatment in the oim mouse model alters bone modeling during growthComparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta.Effects of denosumab treatment and discontinuation on human growth plates.Bisphosphonate use in conditions other than osteoporosis.Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.Fracture after bisphosphonate treatment in children with cerebral palsy: the role of stress risers.Osteogenesis imperfecta in adults: phenotypic characteristics and response to treatment in an Irish cohort.Osteogenesis imperfecta: diagnosis and treatment.Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age.Long-Term Bisphosphonate Therapy in Osteogenesis Imperfecta.Denosumab: an Emerging Therapy in Pediatric Bone Disorders.Pediatric Osteoporosis: Diagnosis and Treatment Considerations.Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care.Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.Osteogenesis imperfecta: potential therapeutic approaches
P2860
Q26830702-45B7216C-66CB-4C35-BCFD-D7A3F4E64B62Q30251490-99CBF342-0DCD-4109-B8AE-B620DE0F0C8DQ33680621-6413E31F-56AC-4921-B2EE-816FD62ECE6EQ33863266-2BBC1C28-7B66-4987-901A-928CCF766774Q34031264-037F2B3A-9E81-42A7-9507-47CF193522CFQ34133308-188E217A-AA26-449E-9538-FAC3EA4EFDA9Q34234347-18FFDA15-9709-4A53-891B-BCB72F8E66C6Q35101807-499B70B5-D99B-4E43-B58F-E0C3BEDC8FBEQ35755200-1A3143BD-9372-46DE-9C9E-FCE3C7473A80Q35919018-BDBF76C7-E4B1-4C46-A347-664E227EBE97Q35969270-6668EEAF-0C10-4004-82D8-89E11F1BB654Q36290920-735664D2-B602-484C-B1AA-F327F3210544Q37079651-F7DD503F-731B-4A5B-9519-5F576758E0FEQ37579579-EF6AC6D8-7132-4A7E-9015-B3F9346A17F3Q37616880-4BAFEFA0-2865-4ED2-8580-2801F60F6DD0Q37800177-849AD7EF-78A1-472B-8143-658DC51741D0Q37807268-A464D3FA-AB24-4D1F-9D29-D1E7799FB335Q37923834-9BD9FFB2-7399-4D45-A56A-C7D5C2B03314Q38126878-1A4E5866-0A63-423D-AD15-AADEA185D8BBQ38223208-1F4C64A8-69F1-4075-B581-CDED358C8323Q38260590-E7DDBB29-87CE-443A-BAA3-379F6D2302DCQ38617388-3580A550-D139-4DBD-B758-BB5411C9B4A4Q38712724-C3127758-10E2-4FAC-B227-0E0CB841B006Q38921958-4533EE5D-1037-40A8-A322-174E29C0539EQ40353392-9B41320A-C520-4810-A6E3-D88742898738Q53472422-329F93F1-2EFE-495A-8FF3-FAA5C3678B0DQ58770323-BE091840-737C-46D2-A259-0604D0916FBC
P2860
Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Long-bone changes after pamidr ...... with osteogenesis imperfecta.
@ast
Long-bone changes after pamidr ...... with osteogenesis imperfecta.
@en
type
label
Long-bone changes after pamidr ...... with osteogenesis imperfecta.
@ast
Long-bone changes after pamidr ...... with osteogenesis imperfecta.
@en
prefLabel
Long-bone changes after pamidr ...... with osteogenesis imperfecta.
@ast
Long-bone changes after pamidr ...... with osteogenesis imperfecta.
@en
P2093
P1433
P1476
Long-bone changes after pamidr ...... with osteogenesis imperfecta.
@en
P2093
Francis H Glorieux
Moira Cheung
Sylvie Cornibert
P304
P356
10.1016/J.BONE.2006.11.020
P50
P577
2007-01-12T00:00:00Z